We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 742

Court of Appeal granted an appeal of the Federal Court's decision allowing internet service provider to charge a fee for disclosure of suspected infringer
  • Borden Ladner Gervais LLP
  • Canada
  • May 18 2017

The Appellants are movie producers and have launched a proposed "reverse" class action against those they say have been downloading their movies


Court dismisses motion for Confidentiality Order
  • Borden Ladner Gervais LLP
  • Canada
  • May 18 2017

The Court dismissed Teva's motion for a confidentiality order. The underlying proceeding is an action by Teva to recover from Janssen and others


Court of Appeal dismisses appeal on the merits from a finding of no trademark infringement but allows appeal in respect of lump sum costs award
  • Borden Ladner Gervais LLP
  • Canada
  • May 18 2017

In this appeal, Venngo appealed from the Federal Court's decision (2015 FC 1338, our summary) dismissing Venngo's claims for trademark infringement


Court of appeal upholds trial judge's finding of no use of the registered design mark
  • Borden Ladner Gervais LLP
  • Canada
  • May 18 2017

This was an appeal of the Federal Court's decision (2016 FC 971) dealing with an appeal from the Registrar of Trademarks in a section 45 proceeding


Reasonable Royalty and Accounting of Profits Determinations Made
  • Borden Ladner Gervais LLP
  • Canada
  • May 10 2017

In a previous decision, which was affirmed, the Court found that Dow's patent was valid and infringed by Nova. Once a finding of liability was made


Court Refuses Motion to Amend Brought After the Commencement of the Quantification Trial
  • Borden Ladner Gervais LLP
  • Canada
  • May 10 2017

This decision concerned the quantification phase following the liability determination, which found AstraZeneca's patent valid and infringed. Apotex


Court sets aside default judgment for failure to give notice to the Defendants' counsel
  • Borden Ladner Gervais LLP
  • Canada
  • May 10 2017

The Ontario Superior Court set aside the default judgment due to the Plaintiff's failure to give notice to the Defendants and to make full and fair


Federal Court Holds That a Request to Find a Dead Patent Application in Good Standing Must Fail
  • Borden Ladner Gervais LLP
  • Canada
  • May 10 2017

The Federal Court has refused to declare that an application is in good standing after the applicants or their agents failed to reply to a requisition


Findings Made in Section 8 Case to Allow Determination of Quantum of Damages
  • Borden Ladner Gervais LLP
  • Canada
  • May 10 2017

In this case, Teva is seeking compensation pursuant to s. 8 of the NOC Regulations for having been prevented from coming to market with its generic


Appeal of TMOB's decision amending the statement of registered goods allowed
  • Borden Ladner Gervais LLP
  • Canada
  • May 3 2017

The Federal Court allowed Lucite's appeal of the Trademarks Opposition Board's (TMOB's) decision amending the registration of its mark to restrict the